Mesenchymal Stem Cells-Based Gene Therapy Approach Mediated by Non-viral Vectors
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Gene and Cell Therapy".
Deadline for manuscript submissions: closed (10 November 2021) | Viewed by 29578
Special Issue Editor
Interests: gene therapy; non-viral vectors; drug delivery; 3D bioprinting; nanotechnology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
The ability to culture expand Mesenchymal Stem Cells (MSCs) easily, differentiate them into different cell types in vitro, in addition to their appealing immunologic characteristics, clearly render MSCs a promising source of stem cells, for gene therapy.
Genetic material transfection could be done for cells in vitro, in vivo and ex vivo. The development of a suitable delivery system to carry the correct gene to the affected target cells is an essential aspect of gene therapy. Safe and effective gene delivery for long-term remains a big challenge for gene therapy.
Recent advances in nanotechnology, material sciences, and nucleic acid chemistry have provided promising non-viral delivery systems, which should increase the potential of MSCs based gene therapy. Non-viral delivery systems show quite a big number of challenges that needs to be circumvented in order to increase their gene transfer effectiveness, especially in MSCs.
Dr. Jon Zárate
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- non-viral delivery systems
- mesenchymal Stem Cells
- gene delivery
- niosomes
- liposomes
- polyplexes
- lipoplexes